Cite
HARVARD Citation
Kondili, L. et al. (2017). Modeling cost‐effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real‐life cohort. Hepatology. 66 (6), pp. 1814-1825. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kondili, L. et al. (2017). Modeling cost‐effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real‐life cohort. Hepatology. 66 (6), pp. 1814-1825. [Online].